Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Dréno B:

Search results

Items: 1 to 20 of 654

1.

The role of exposome in acne: results from an international patient survey.

Dreno B, Shourick J, Kerob D, Bouloc A, Taïeb C.

J Eur Acad Dermatol Venereol. 2019 Nov 30. doi: 10.1111/jdv.16119. [Epub ahead of print]

PMID:
31785166
2.

A T-helper 1/interferon- gene signature is prognostic in the adjuvant setting of resectable high-risk melanoma but not in non-small cell lung cancer.

Dizier B, Callegaro A, Debois M, Dreno B, Hersey P, Gogas HJ, Kirkwood JM, Vansteenkiste JF, Sequist LV, Atanackovic D, Goeman J, van Houwelingen H, Salceda S, Wang F, Therasse P, Debruyne C, Spiessens B, Brichard VG, Louahed J, Ulloa-Montoya F.

Clin Cancer Res. 2019 Nov 15. pii: clincanres.3717.2018. doi: 10.1158/1078-0432.CCR-18-3717. [Epub ahead of print]

PMID:
31732522
3.

Acne fulminans and Cutibacterium acnes phylotypes.

Bocquet-Trémoureux S, Corvec S, Khammari A, Dagnelie MA, Boisrobert A, Dreno B.

J Eur Acad Dermatol Venereol. 2019 Nov 12. doi: 10.1111/jdv.16064. [Epub ahead of print]

PMID:
31715640
4.

Acne from the young patient's perspective.

Claudel JP, Auffret N, Leccia MT, Poli F, Dréno B.

J Eur Acad Dermatol Venereol. 2019 Nov 12. doi: 10.1111/jdv.16067. [Epub ahead of print] Review.

PMID:
31715036
5.

CICAFAST: comparison of a biological dressing composed of fetal fibroblasts and keratinocytes on a split-thickness skin graft donor site versus a traditional dressing: a randomized controlled trial.

Poinas A, Perrot P, Lorant J, Nerrière O, Nguyen JM, Saiagh S, Frenard C, Leduc A, Malard O, Espitalier F, Duteille F, Chiffoleau A, Vrignaud F, Khammari A, Dréno B.

Trials. 2019 Oct 28;20(1):612. doi: 10.1186/s13063-019-3718-4.

6.

Quality-of-life assessment in French patients with metastatic melanoma in real life.

Kandel M, Dalle S, Bardet A, Allayous C, Mortier L, Dutriaux C, Guillot B, Leccia MT, Dalac S, Legoupil D, Saiag P, Montaudie H, Arnault JP, Brunet-Possenti F, Grob JJ, DeQuatrebarbes J, Beylot-Barry M, Lesimple T, Aubin F, Maubec E, Granel-Brocard F, Stoebner PE, Dupuy A, Dreno B, Michiels S, Lebbe C, Borget I.

Cancer. 2019 Oct 22. doi: 10.1002/cncr.32554. [Epub ahead of print]

PMID:
31639198
7.

Bacterial extracellular vesicles: A new way to decipher host-microbiota communications in inflammatory dermatoses.

Dagnelie MA, Corvec S, Khammari A, Dréno B.

Exp Dermatol. 2019 Oct 21. doi: 10.1111/exd.14050. [Epub ahead of print] Review.

PMID:
31633842
8.

Safety review of phenoxyethanol when used as a preservative in cosmetics.

Dréno B, Zuberbier T, Gelmetti C, Gontijo G, Marinovich M.

J Eur Acad Dermatol Venereol. 2019 Nov;33 Suppl 7:15-24. doi: 10.1111/jdv.15944. Review.

PMID:
31588615
9.

Safety of titanium dioxide nanoparticles in cosmetics.

Dréno B, Alexis A, Chuberre B, Marinovich M.

J Eur Acad Dermatol Venereol. 2019 Nov;33 Suppl 7:34-46. doi: 10.1111/jdv.15943. Review.

PMID:
31588611
10.

Development and accuracy of an artificial intelligence algorithm for acne grading from smartphone photographs.

Seité S, Khammari A, Benzaquen M, Moyal D, Dréno B.

Exp Dermatol. 2019 Aug 25. doi: 10.1111/exd.14022. [Epub ahead of print]

PMID:
31446631
11.

Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM.

Lewis KD, Larkin J, Ribas A, Flaherty KT, McArthur GA, Ascierto PA, Dréno B, Yan Y, Wongchenko M, McKenna E, Zhu Q, Mun Y, Hauschild A.

Br J Cancer. 2019 Oct;121(7):522-528. doi: 10.1038/s41416-019-0546-y. Epub 2019 Aug 16.

12.

Effect of Indoleamine 2,3 Dioxygenase Inhibitor on the Cytotoxic Activity of Tumour-infiltrating Lymphocytes.

Le Naour S, Knol AC, Pandolfino MC, Khammari A, Dréno B.

Acta Derm Venereol. 2019 Nov 1;99(12):1186-1187. doi: 10.2340/00015555-3285. No abstract available.

13.

Efficacy and safety of nivolumab in metastatic melanoma: real-world practice.

Bocquet-Tremoureux S, Scharbarg E, Nguyen JM, Varey E, Quereux G, Saint-Jean M, Peuvrel L, Khammari A, Dreno B.

Eur J Dermatol. 2019 Jun 1;29(3):315-321. doi: 10.1684/ejd.2019.3558.

PMID:
31389790
14.

[Successful completion of an ISO 9001 v 2015 certification process in clinical investigation research].

Gibouleau C, Padioleau C, Poinas A, Vrignaud F, Deblois S, Galisson IM, Lecerf P, Fuzeau C, Dreno B, Trochu JN, Sacher Huvelin S.

Therapie. 2019 Dec;74(6):665-674. doi: 10.1016/j.therap.2019.06.003. Epub 2019 Jun 26. French.

PMID:
31307678
15.

Cutibacterium acnes phylotypes diversity loss: a trigger for skin inflammatory process.

Dagnelie MA, Corvec S, Saint-Jean M, Nguyen JM, Khammari A, Dréno B.

J Eur Acad Dermatol Venereol. 2019 Dec;33(12):2340-2348. doi: 10.1111/jdv.15795. Epub 2019 Aug 20.

PMID:
31299116
16.

Gut dysbiosis: not only with checkpoint inhibitors!

Piroth M, Frenard C, Quereux G, Khammari A, Corvec S, Dréno B.

Clin Exp Dermatol. 2019 Jun 21. doi: 10.1111/ced.14018. [Epub ahead of print] No abstract available.

PMID:
31222907
17.

Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.

Dréno B, Bissonnette R, Gagné-Henley A, Barankin B, Lynde C, Chavda R, Kerrouche N, Tan J.

Am J Clin Dermatol. 2019 Oct;20(5):725-732. doi: 10.1007/s40257-019-00454-6.

PMID:
31209851
18.

Effect of concomitant dosing with acid-reducing agents and vemurafenib dose on survival in patients with BRAFV600 mutation-positive metastatic melanoma treated with vemurafenib ± cobimetinib.

Lewis K, Hauschild A, Larkin J, Ribas A, Flaherty KT, McArthur GA, Dréno B, McKenna E, Zhu Q, Mun Y, Ascierto PA.

Eur J Cancer. 2019 Jul;116:45-55. doi: 10.1016/j.ejca.2019.05.002. Epub 2019 Jun 4.

PMID:
31173962
19.

Inflammatory skin is associated with changes in the skin microbiota composition on the back of severe acne patients.

Dagnelie MA, Montassier E, Khammari A, Mounier C, Corvec S, Dréno B.

Exp Dermatol. 2019 Aug;28(8):961-967. doi: 10.1111/exd.13988. Epub 2019 Jul 3.

PMID:
31173650
20.

First case of cutaneous sarcoidosis within tattoos under durvalumab.

Rousseau PM, Raimbourg J, Robert M, Dansette D, Dréno B, Peuvrel L; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments.

Int J Dermatol. 2019 Sep;58(9):e168-e170. doi: 10.1111/ijd.14484. Epub 2019 Jun 4. No abstract available.

PMID:
31162632

Supplemental Content

Loading ...
Support Center